NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0002-8214-05 | 0002-8214 | HUMAN PRESCRIPTION DRUG | BASAGLAR Tempo Pen | Insulin glargine | INJECTION, SOLUTION | SUBCUTANEOUS | 20191115 | N/A | BLA | BLA205692 | Eli Lilly and Company | INSULIN GLARGINE | 100 [iU]/mL | 5 SYRINGE in 1 CARTON (0002-8214-05) / 3 mL in 1 SYRINGE (0002-8214-01) |
0002-7715-59 | 0002-7715 | HUMAN PRESCRIPTION DRUG | BASAGLAR KwikPen | Insulin glargine | INJECTION, SOLUTION | SUBCUTANEOUS | 20160617 | N/A | BLA | BLA205692 | Eli Lilly and Company | INSULIN GLARGINE | 100 [iU]/mL | 5 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01) |
0002-7715-63 | 0002-7715 | HUMAN PRESCRIPTION DRUG | BASAGLAR KwikPen | Insulin glargine | INJECTION, SOLUTION | SUBCUTANEOUS | 20160715 | N/A | BLA | BLA205692 | Eli Lilly and Company | INSULIN GLARGINE | 100 [iU]/mL | 1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE |